EUVIMEDEUVIMED entdecken
Crossref

Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine

Peter Lee iD, Sebastien Bubeck, Joseph Petro

New England Journal of Medicine · 30.03.2023 · 388 (13) · 1233-1239

DOI: 10.1056/nejmsr2214184 ↗

Kurz gefasst

Fachartikel in der Zeitschrift New England Journal of Medicine, erschienen am 30.03.2023. Verfasst von Peter Lee und 2 weiteren Autor:innen. Beteiligte Einrichtung: From Microsoft Research, Redmond, WA (P.L., S.B.); and Nuance Communications, Burlington, MA (J.P.). Hauptthemen laut MEDLINE: Artificial Intelligence, Medicine. Die Arbeit wurde bisher 1779-mal zitiert (Crossref) und nennt 11 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chatbots are computer programs with which one can have a conversation. In this article, the authors describe how the GPT-4 chatbot, which has been given a general education, could affect the practice of medicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Artificial IntelligenceMedicineHumansRisk Assessment

Autor:innen und Institutionen

  • From Microsoft Research, Redmond, WA (P.L., S.B.); and Nuance Communications, Burlington, MA (J.P.).

ORCID-Profile: Peter Lee

Zitieren

APA

Lee, P., Bubeck, S., & Petro, J. (2023). Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine. New England Journal of Medicine, 388(13), 1233-1239. https://doi.org/10.1056/nejmsr2214184

Vancouver

Lee P, Bubeck S, Petro J. Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine. New England Journal of Medicine. 2023;388(13):1233-1239. doi:10.1056/nejmsr2214184

BibTeX
@article{Lee2023,
  author = {Lee, Peter and Bubeck, Sebastien and Petro, Joseph},
  title = {Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine},
  journal = {New England Journal of Medicine},
  year = {2023},
  volume = {388},
  number = {13},
  pages = {1233--1239},
  doi = {10.1056/nejmsr2214184}
}
Kostenlos starten →